Nexalin Technology Receives Nasdaq Delisting Warning for Minimum Bid Price Deficiency

summarizeSummary

Nexalin Technology, Inc. received a notice from Nasdaq for failing to meet the minimum $1.00 bid price requirement, initiating a 180-day compliance period to avoid potential delisting.

check_boxKey Events

• Nasdaq Deficiency Notice Received

  On January 21, 2026, Nexalin Technology, Inc. received a notice from Nasdaq for non-compliance with the $1.00 minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)).

• 180-Day Compliance Period Initiated

  The company has 180 calendar days, until July 20, 2026, to regain compliance by maintaining a closing bid price of $1.00 or more for a minimum of ten consecutive business days.

• Risk of Delisting and OTC Trading

  Failure to regain compliance could result in delisting from Nasdaq, with the company expecting its common stock to then trade on one of the OTC Markets Group's tiered marketplaces.

• Current Stock Price Below Threshold

  The company's common stock currently trades at $0.61, significantly below the required $1.00 minimum bid price.

auto_awesomeAnalysis

Nexalin Technology, Inc. has received a deficiency letter from Nasdaq for failing to maintain the required $1.00 minimum bid price for its common stock. This notice triggers a 180-calendar-day compliance period, ending July 20, 2026, during which the company must achieve a closing bid price of $1.00 or more for at least ten consecutive business days. Failure to regain compliance could lead to delisting from The Nasdaq Capital Market, potentially forcing the stock to trade on the less liquid OTC Markets Group. The current stock price of $0.61 is significantly below the required threshold, indicating a substantial challenge for the company. While the company states it is not considering a reverse stock split at this time, this situation poses a material risk to its listing status and investor confidence.